The 3′,5′-cyclic guanosine monophosphate (cGMP) pathway triggers cytoprotective responses and improves cardiomyocyte survival during myocardial ischemia and reperfusion (I/R) injury. These beneficial effects were attributed to NO-sensitive guanylyl cyclase (GC) induced cGMP production leading to activation of cGMP-dependent protein kinase I (cGKI). Cyclic GKI in turn causes phosphorylation of multiple substrates, which eventually facilitates opening of mitochondrial ATP-sensitive potassium channels (mitoK ) and Ca -activated potassium channels of the BK type (mitoBK). Accordingly, agents activating mitoK or mitoBK provide protection against I/R-induced damages. Here we give an up-to-date summary of the infarct-limiting actions exhibited by the GC/cGMP axis and discuss how mitoK and mitoBK, which are present at the inner mitochondrial membrane, confer mito- and cytoprotective effects on cardiomyocytes exposed to I/R injury. In view of this, we believe that the functional connection between the cGMP cascade and mitoK channels should be exploited further as adjunct to reperfusion therapy in myocardial infarction.
This article is protected by copyright. All rights reserved.

Author